Arcus Biosciences, Inc. (NYSE:RCUS) Expected to Post FY2024 Earnings of ($2.64) Per Share
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Stock analysts at Wedbush raised their FY2024 EPS estimates for Arcus Biosciences in a research report issued on Tuesday, January 30th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings per share of ($2.64) for the year, up from their previous estimate of ($4.11). […]
More Stories
Verizon Communications Inc. (NYSE:VZ) Shares Acquired by TrinityPoint Wealth LLC
TrinityPoint Wealth LLC lifted its stake in shares of Verizon Communications Inc. (NYSE:VZ – Free Report) by 3.2% during the...
TrinityPoint Wealth LLC Purchases 75,333 Shares of Invesco BulletShares 2027 Corporate Bond ETF (NASDAQ:BSCR)
TrinityPoint Wealth LLC boosted its position in Invesco BulletShares 2027 Corporate Bond ETF (NASDAQ:BSCR – Free Report) by 75.3% during...
2,465 Shares in Novanta Inc. (NASDAQ:NOVT) Acquired by Chesapeake Capital Corp IL
Chesapeake Capital Corp IL purchased a new position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) during the third...
Chesapeake Capital Corp IL Takes Position in Applied Digital Co. (NASDAQ:APLD)
Chesapeake Capital Corp IL acquired a new stake in Applied Digital Co. (NASDAQ:APLD – Free Report) during the 3rd quarter,...
Chesapeake Capital Corp IL Has $273,000 Stake in The Greenbrier Companies, Inc. (NYSE:GBX)
Chesapeake Capital Corp IL increased its position in shares of The Greenbrier Companies, Inc. (NYSE:GBX – Free Report) by 27.9%...
Swiss National Bank Sells 8,000 Shares of Marriott International, Inc. (NASDAQ:MAR)
Swiss National Bank decreased its position in shares of Marriott International, Inc. (NASDAQ:MAR – Free Report) by 1.1% in the...